Insights

Advanced Radiation Solutions IBA's leadership in proton therapy and particle accelerator technology presents significant opportunities to sell cutting-edge irradiation equipment and services to medical institutions seeking to expand or upgrade their radiotherapy capabilities.

Industrial Expansion The recent contract with Jabil to install X-ray sterilization solutions signals potential for sales in industrial irradiation and sterilization sectors, especially as companies invest in modernizing their manufacturing and sterilization processes.

Growing Market Presence IBA's increasing global footprint, evidenced by recent installations in India and the USA, creates opportunities to target regional hospitals and medical centers interested in compact, efficient proton therapy systems and particle accelerators.

Innovative Radioisotopes Through its joint venture PanTera, IBA is positioned to offer advanced actinium-225, which could open sales channels to pharmaceutical and research laboratories dedicated to developing targeted cancer treatments.

Sustainable & Certified As a B Corporation with verified social and environmental standards, IBA appeals to healthcare organizations and industrial clients seeking environmentally responsible and socially conscious partners, thus expanding potential customer base in sustainability-focused markets.

IBA Tech Stack

Media & News

IBA's Email Address Formats

IBA uses at least 1 format(s):
IBA Email FormatsExamplePercentage
First.Last@iba-group.comJohn.Doe@iba-group.com
94%
FLast@iba-group.comJDoe@iba-group.com
4%
Last@iba-group.comDoe@iba-group.com
1%
First.MiddleLast@iba-group.comJohn.MichaelDoe@iba-group.com
1%

Frequently Asked Questions

What is IBA's stock symbol?

Minus sign iconPlus sign icon
IBA is a publicly traded company; the company's stock symbol is IBA.

What is IBA's official website and social media links?

Minus sign iconPlus sign icon
IBA's official website is iba-group.com and has social profiles on LinkedIn.

How much revenue does IBA generate?

Minus sign iconPlus sign icon
As of December 2025, IBA's annual revenue is estimated to be $17M.

What is IBA's NAICS code?

Minus sign iconPlus sign icon
IBA's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does IBA have currently?

Minus sign iconPlus sign icon
As of December 2025, IBA has approximately 3K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Ceo: O. L.Ceo: I. S.Chief Executive Officer: I. A.. Explore IBA's employee directory with LeadIQ.

What industry does IBA belong to?

Minus sign iconPlus sign icon
IBA operates in the Medical Equipment Manufacturing industry.

What is IBA's email format?

Minus sign iconPlus sign icon
IBA's email format typically follows the pattern of First.Last@iba-group.com. Find more IBA email formats with LeadIQ.

When was IBA founded?

Minus sign iconPlus sign icon
IBA was founded in 1986.

IBA

Medical Equipment ManufacturingFlanders, Belgium1001-5000 Employees

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered to be the most advanced form of radiation therapy available today, industrial sterilization, radiopharmaceuticals and dosimetry. 

The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

Section iconCompany Overview

Stock Symbol
IBA
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
1986
Employees
1001-5000

Section iconFunding & Financials

  • $500M$1B

    IBA's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $500M$1B

    IBA's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.